NVAX US6700024010

Report

Delayed Nasdaq - 04:00 2022-07-06 pm EDT
63.54	USD		-1.17%

09:05a	Novavax Nuvaxovid COVID-19 Vaccine Conditionally Authorized in the European Union for Adolescents Aged 12 Through 17	AQ
07/05	SECTOR UPDATE : Health Care Stocks Struggle Tuesday	MT
07/05	SECTOR UPDATE : Health Care Stocks Retreating in Tuesday Trade	MT

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

06/29/2022	06/30/2022	07/01/2022	07/05/2022	07/06/2022	Date
51.85(c)	51.43(c)	57.15(c)	64.29(c)	63.54	Last
4 113 231	3 556 907	6 423 652	7 175 284	5 869 935	Volume
+1.55%	-0.81%	+11.12%	+12.49%	-1.17%	Change

More quotes

Estimated financial data (e) (USD)

Sales 2022	4 384 M - -
Net income 2022	2 019 M - -
Net cash position 2022	2 508 M - -
P/E ratio 2022	2,57x
Yield 2022	-

Sales 2023	3 086 M - -
Net income 2023	916 M - -
Net cash position 2023	3 354 M - -
P/E ratio 2023	6,09x
Yield 2023	-

Capitalization	5 023 M 5 023 M -
EV / Sales 2022	0,57x
EV / Sales 2023	0,54x
Nbr of Employees	1 541
Free-Float	98,8%

More Financials

Company

Novavax, Inc., along with its wholly owned subsidiaries, Novavax AB and Novavax CZ, is a biotechnology company. The Company promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address...

Sector

Biotechnology & Medical Research

Calendar

More about the company

Ratings of Novavax, Inc.

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

All news about NOVAVAX, INC.

09:05a	Novavax Nuvaxovid COVID-19 Vaccine Conditionally Authorized in the European Union for A..	AQ
07/05	SECTOR UPDATE : Health Care Stocks Struggle Tuesday	MT
07/05	SECTOR UPDATE : Health Care Stocks Retreating in Tuesday Trade	MT
07/05	Novavax Says COVID-19 Vaccine Conditionally Authorized in the EU for Adolescents	MT
07/05	Novavax Nuvaxovid™ COVID-19 Vaccine Conditionally Authorized in the European Unio..	PR
07/05	Novavax Nuvaxovid™ COVID-19 Vaccine Conditionally Authorized in the European Unio..	AQ
07/05	Novavax, Inc. Announces European Commission Approves Expanded Conditional Marketing Aut..	CI
07/05	EMA's CHMP Approves New Manufacturing Site For Active Substance Of COVID-19 Vaccine Nuv..	RE
07/04	Novavax Statement on Prototype Vaccine's Broad Immune Responses and Accelerated Focus o..	AQ
07/01	Novavax Targets Q4 Release of Omicron-Containing Vaccine; Shares Rise	MT
07/01	Novavax expects COVID vaccine targeting Omicron in fourth quarter	RE
06/29	Novavax to Participate in Vaccines and Related Biological Products Advisory Committee R..	AQ
06/29	BioNTech, Pfizer to starting testing universal coronavirus vaccine in H2	RE
06/29	Taiwan to receive first doses of Novavax COVID vaccine this week	RE
06/28	Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Respo..	PR

More news

News in other languages on NOVAVAX, INC.

07/05	MISE À JOUR SECTORIELLE : Les actions du secteur de la santé en difficulté mardi
07/05	MISE À JOUR SECTORIELLE : Les actions du secteur de la santé reculent dans les échanges de..
07/05	Novavax déclare que le vaccin COVID-19 est autorisé sous condition dans l'UE pour les a..
07/05	Novavax, Inc. annonce que la Commission européenne approuve l'extension de l'autorisati..
07/01	Novavax prévoit la mise sur le marché d'un vaccin contenant de l'Omicron au quatrième t..

More news

Analyst Recommendations on NOVAVAX, INC.

06/08	Cantor Fitzgerald Adjusts Price Target on Novavax to $168 From $146, Reiterates Overwei..	MT
06/06	Cantor Fitzgerald Adjusts Price Target on Novavax to $146 From $189, Reiterates Overwei..	MT
05/20	BofA Securities Initiates Coverage on Novavax With Underperform Rating	MT

More recommendations

Provided by Scoopnest.com

Analysis

COVID-19 vaccine scheme for world's poorest pushes for delivery slowdown